<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="utf-8">
    <meta http-equiv="X-UA-Compatible" content="IE=edge">
    <meta content="width=device-width, initial-scale=1, maximum-scale=1, user-scalable=no" name="viewport">
    <meta name="description" content="نظام معلومات الأدوية السعودي Saudi Drugs Information System">
    <meta name="author" content="Saudi Food & Drug Authority (SFDA)">
    <noscript><meta http-equiv="refresh" content="0; url=/noScript.html" /></noscript>
    <link rel="shortcut icon" href="/favicon.ico">
    <title>&#x646;&#x638;&#x627;&#x645; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</title>
    <link href="/fonts/roboto/roboto.css?v=53F8z0aw8DRnG9ou9x1tuKMPbNjRZWM-VBHl3B0s9-o" rel="stylesheet" />
    <link href="/fonts/material-icons/materialicons.css?v=8pEJ8MWsFzHRDLY0NI5rssf6T6vankxrJDPnnZxOGrg" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-rtl.css?v=0env-Atj9mTPLILmJGwuDlLIOS_Akxxy4gnH1UUtrjU" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-glyphicons.css?v=U5a39oen_WYzVAAexH5aoahbpqlKHcIzQrnXujf1yio" rel="stylesheet" />
    <link href="/lib/bootstrap-select/dist/css/bootstrap-select.css?v=DeY2lH0e0tmNnO9XZ-gGVOGk6_YoWlZ49y7CnD3ST00" rel="stylesheet" />
    <link href="/lib/toastr/toastr.css?v=kKePN_CyxTiMEgsSDu_7z21ru07YOZtR-0UV0JOkt5o" rel="stylesheet" />
    <link href="/lib/famfamfam-flags/dist/sprite/famfamfam-flags.css?v=JVJiF3s2_kk99xQHfYhfxo_-Dd52ZIruDMOILwPkqv0" rel="stylesheet" />
    <link href="/lib/font-awesome/css/font-awesome.css?v=YIHlqxkiJtENTMuzIHC9EfZaB5RniGr7kF7juUQJUuc" rel="stylesheet" />
    <link href="/lib/Waves/dist/waves.css?v=nd3hxjNg6DhkuFIz5IbxLK8Xw2ac0blsDQpF4pkJxUc" rel="stylesheet" />
    <link href="/lib/animate.css/animate.css?v=IT6GQizZpVcaM1_L_mIiNAYVvZErMgfwewf1GGWXG_I" rel="stylesheet" />
    <link href="/css/materialize.css?v=ey-J3xahkqficOYUHVX3jexmzvRFrge9bmux4CQr1DQ" rel="stylesheet" />
    <link href="/css/Publicstyle.css?v=xhOiVjq-54ODzSIeHXoascHsEJm_n_bIHqZatpxnYhg" rel="stylesheet">
    <link href="/css/Comman.css?v=bcS6_IRqBsBcY1mS_iriWWanrYR0Scdo1ffk8rQGXwQ" rel="stylesheet" />
    <link href="/css/themes/all-themes.css?v=eGSl5zNTWrXYfUx_EJW9ksC3CUTUUxvxmPiA3aQDtQo" rel="stylesheet" />
    <link href="/view-resources/Views/Shared/_Layout.css?v=BLxBuNISlF2O5EBHWdsX039NvnIHy-GtcqeI_MbyIc0" rel="stylesheet" />
    <link href="/lib/enjoyhint/enjoyhint.css?v=rSxIyBbiAvx_48ZcFxbn2DNPCCgEc0FXa2Vb72enxk4" rel="stylesheet" />
    <link href="/lib/dropzone/dropzone.css?v=IQDlHJdeYZ4gMH87EuB1yEG7ujA7DSEkV_SWfACk8Rg" rel="stylesheet" />

    <!-- View specific styles -->
    
    <script type="text/javascript" nonce="c7f26c8w">
        // This is used to get the application's root path from javascript. It's useful if you're running application in a virtual directory under IIS.
        var abp = abp || {};
        abp.appPath = '/';

    </script>
    <style>
        .popover .popover-title {
            text-align: right;
            font-weight: bold;
        }
        .popover .popover-content {
            text-align: right;
            font-size: 14px;
            font-family: 'Almarai', sans-serif;
            color: black;
        }
       
    </style>
</head>
<body>
    <!-- Page Loader -->
    <div class="page-loader-wrapper">
        <div class="loader">
            <div class="preloader">
                <div class="spinner-layer pl-blue">
                    <div class="circle-clipper left">
                        <div class="circle"></div>
                    </div>
                    <div class="circle-clipper right">
                        <div class="circle"></div>
                    </div>
                </div>
            </div>
            <p>&#x628;&#x631;&#x62C;&#x627;&#x621; &#x627;&#x644;&#x625;&#x646;&#x62A;&#x638;&#x627;&#x631; ...</p>
        </div>
    </div>
    <!-- #END# Page Loader -->
    <!-- Overlay For Sidebars -->
    <div class="overlay"></div>
    <!-- #END# Overlay For Sidebars -->
    <!-- Search Bar -->
    <!-- Top Bar -->
    <nav class="navbar navbar-inverse naav" style="margin-bottom: 0;">
        <div class="container-fluid">
            <div class="navbar-header">
                <button type="button" class="navbar-toggle" data-toggle="collapse" data-target="#myNavbar">
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                </button>
            </div>
            <div class="collapse navbar-collapse rtl" id="navbar-collapse">
                <ul class="nav navbar-nav navbar-right">
                    <li><a href="/home/DrugSearch">&#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</a></li>
                        <li><a href="/Account/Login"><i class="fa fa-key"></i>&nbsp;&#x62A;&#x633;&#x62C;&#x64A;&#x644; &#x627;&#x644;&#x62F;&#x62E;&#x648;&#x644;</a></li>
                </ul>
                <ul class="nav navbar-nav navbar-left">
                    <li class="dropdown">
    <a href="javascript:void(0);" class="dropdown-toggle" data-toggle="dropdown" role="button">
        <i class="famfamfam-flags sa" title="&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;"></i>
        <span>&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</span>
        <b class="caret"></b>
    </a>
    <ul class="dropdown-menu pull-right">
                <li><a href="/AbpLocalization/ChangeCulture?cultureName=en"><i class="famfamfam-flags gb"></i> English</a></li>

    </ul>
</li>

                </ul>
            </div>
        </div>
    </nav>
    <section id="mainContent" class="content">
        <nav class="navbar naav" style="margin-bottom: 0;">
            <div class="container-fluid">
                <ul class="nav navbar-nav">
                    <li>
                        <a class="text-center" href="/">
                            <img src="/images/logo_sdi.png" style="margin: auto;" width="250">
                        </a>
                    </li>
                </ul>
                <div class="navbar-header navbar-toggle2 ">
                    <button type="button" class="navbar-toggle navbar-toggle2" data-toggle="collapse"
                            data-target="#myNavbar2">
                        <span class="icon-bar icon-bar2 "></span>
                        <span class="icon-bar icon-bar2"></span>
                        <span class="icon-bar icon-bar2"></span>
                    </button>
                </div>
                <div class="collapse navbar-collapse " id="myNavbar2">
                    <ul class="nav navbar-nav">
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover" data-placement="bottom" title="" data-content="موقع الكترونى يمكن شركات ووكلاء الادويه من رفع النشرات الممارس الصحى ونشرة معلومات المريض وصورة عبوة الدواء المعتمدة من الهيئة العامة للعذاء والدواء بهدف بناء مرجع وطنى للادوية المسجلة يمكن الرجوع له من قبل الممارس الصحى والمريض كمصدر موثوق للمعلومات الدوائية"
                               data-original-title="&#x645;&#x646; &#x646;&#x62D;&#x646;">
                                &#x645;&#x646; &#x646;&#x62D;&#x646;
                            </a>
                        </li>
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover"
                               data-placement="bottom"
                               title=""
                               data-content="&#x627;&#x630;&#x627; &#x643;&#x627;&#x646; &#x644;&#x62F;&#x64A;&#x643;&#x645; &#x645;&#x644;&#x627;&#x62D;&#x638;&#x627;&#x62A; &#x627;&#x648; &#x627;&#x642;&#x62A;&#x631;&#x627;&#x62D;&#x627;&#x62A; &#x64A;&#x631;&#x62C;&#x649; &#x627;&#x644;&#x62A;&#x648;&#x627;&#x635;&#x644; &#x639;&#x644;&#x649;   SDI@SFDA.GOV.SA"
                               data-original-title="&#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;">
                                &#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;
                            </a>
                        </li>

                    </ul>
                </div>
            </div>
        </nav>
        

<div class="col-xs-12">
    <div class="row text-center">
        <a href="/" class="btn bg-blue btn-lg m-b-10 hover-white">&#x628;&#x62D;&#x62B; &#x62C;&#x62F;&#x64A;&#x62F;</a>
    </div>
</div>
<div class="jumbotron" style="margin-bottom: 0px; background-color: white !important;">
    <h3 class="text-center" style="color: #57aabf; ">Search Results</h3>
    <hr width="20%" style="border-top: 3px solid #54ae90;">

    <br>
    <table class="table s-row">
        <thead style="margin-bottom: 30px !important">
                <tr>
                    <th id="M" style="color:white;">
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x627;&#x644;&#x645;&#x645;&#x627;&#x631;&#x633; &#x627;&#x644;&#x635;&#x62D;&#x64A;</a>
                    </th>
                    <th id="A" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</a>
                    </th>
                    <th id="E" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x627;&#x646;&#x62C;&#x644;&#x64A;&#x632;&#x64A;&#x629;</a>
                    </th>
                    <th id="f" class="active-tab" type='button'>
                        <a href="javascript:void(0)" style="color: white;">&#x635;&#x648;&#x631; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>
                    <th id="D" style="color:white; background-color: #47a4ba;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x628;&#x64A;&#x627;&#x646;&#x627;&#x62A; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>

                </tr>
        </thead>
    </table>
    <div id="D-div" class="box-data" style="display: block;">
        <div class="row">

<div class="modal-body rtl">
    <div class="tab-content">
        <div role="tabpanel" class="tab-pane m-r-60  animated fadeIn active" id="edit-user-details">
<div class="row clearfix">
                    <div class="col-lg-6 col-md-6 col-sm-6">
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="RegisterNumber">&#x631;&#x642;&#x645; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        3007245702
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="RegisterYear">&#x633;&#x646;&#x629; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        2018
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="TradeName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x62A;&#x62C;&#x627;&#x631;&#x64A;</label>
                                    <div class="form-line">
                                        RAMEP 20 MG GASTRO-RESISTANT TABLET
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="ScientificName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x639;&#x644;&#x645;&#x64A;</label>
                                    <div class="form-line">
                                        RABEPRAZOLE SODIUM
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label " for="Strength">&#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        20
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="StrengthUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="AdministrationRouteName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x625;&#x633;&#x62A;&#x639;&#x645;&#x627;&#x644;</label>
                                    <div class="form-line">
                                        Oral use
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PharmaceuticalFormName">&#x627;&#x644;&#x634;&#x643;&#x644; &#x627;&#x644;&#x635;&#x64A;&#x62F;&#x644;&#x627;&#x646;&#x64A;</label>
                                    <div class="form-line">
                                        Gastro-resistant tablet
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Size">&#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="SizeUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageSize">&#x62D;&#x62C;&#x645; &#x627;&#x644;&#x639;&#x628;&#x648;&#x629;</label>
                                    <div class="form-line">
                                        28
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageTypeName">&#x627;&#x646;&#x648;&#x627;&#x639; &#x627;&#x644;&#x639;&#x628;&#x648;&#x627;&#x62A;</label>
                                    <div class="form-line">
                                        Blister
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="LegalStatusName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x635;&#x631;&#x641;</label>
                                    <div class="form-line">
                                        Prescription
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="ProductControlName">&#x62D;&#x627;&#x644;&#x629; &#x627;&#x644;&#x645;&#x631;&#x627;&#x642;&#x628;&#x629;</label>
                                    <div class="form-line">
                                        Uncontrolled
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="DrugTypeName">&#x646;&#x648;&#x639; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</label>
                                    <div class="form-line">
                                        Generic
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="ShelfLife">&#x645;&#x62F;&#x629; &#x627;&#x644;&#x635;&#x644;&#x627;&#x62D;&#x64A;&#x629; &#x628;&#x627;&#x644;&#x623;&#x634;&#x647;&#x631;</label>
                                    <div class="form-line">
                                        24
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="StorageConditionsName">&#x634;&#x631;&#x648;&#x637; &#x627;&#x644;&#x62A;&#x62E;&#x632;&#x64A;&#x646;</label>
                                    <div class="form-line">
                                        store below 30°c
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Price">&#x633;&#x639;&#x631; &#x627;&#x644;&#x62C;&#x645;&#x647;&#x648;&#x631; &#x628;&#x627;&#x644;&#x631;&#x64A;&#x627;&#x644;  ( &#x627;&#x644;&#x633;&#x639;&#x631; )</label>
                                    <div class="form-line">
                                        30.15
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Manufacture_NameEn" name="Manufacture.NameEn" value="Novartis Pharmaceutical Manufacturing LLC" />
                                        <label class="form-label" for="Manufacture_NameEn">&#x627;&#x644;&#x645;&#x635;&#x646;&#x639;</label>
                                        <div class="form-line">
                                            Novartis Pharmaceutical Manufacturing LLC
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Agent" name="Agent" value="[Agent 360]" />
                                        <label class="form-label">&#x627;&#x644;&#x648;&#x643;&#x64A;&#x644;</label>
                                        <div class="form-line">
                                            Farouk, Maamoun Tamer & CO
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <label class="form-label" for="Company_NameEn">&#x627;&#x644;&#x634;&#x631;&#x643;&#x629; &#x627;&#x644;&#x645;&#x633;&#x648;&#x642;&#x629;</label>
                                        <div class="form-line">
                                            SANDOZ
                                        </div>
                                    </div>
                                </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode1">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 1</label>
                                    <div class="form-line">
                                        A02BC04 
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode2">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 2</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                    </div>
                </div>
        </div>
    </div>
</div>

        </div>
    </div>
    <div id="E-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> SFDA PIL</span>
                <span style="font-size:small;">  (Patient Information Leaflet (PIL) are under review by Saudi Food and Drug Authority)</span>

            </div>
</div>


<div class="clearfix ltr">
    <div class="col-lg-12 col-md-12 col-sm-12 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="InventedNameEn">1. What this product is and what it is used for</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Rabeprazole belongs to a group of medicines called &ldquo;proton pump inhibitors&rdquo;. These medicines</p><p>reduce the production of acid in your stomach.</p><p>Ramep&trade; is used for treating the following conditions in adults:</p><p> ulcers in the gut (also called duodenal ulcer)</p><p> ulcers in the stomach (also called benign gastric ulcer)</p><p> relieving the symptoms of heartburn caused by erosive or ulcerative gastro-oesophageal</p><p>reflux disease (GORD) which is also called reflux oesophagitis</p><p> long-term treatment of GORD to prevent it re-occurring</p><p> relieving the symptoms of moderate to very severe GORD (symptomatic GORD) like</p><p>heartburn and acid regurgitation</p><p> severely increased acid secretion in the stomach (Zollinger-Ellison syndrome)</p><p> treatment of infections caused by bacteria called <em>Helicobacter pylori </em>(<em>H pylori</em>) when given in</p><p>combination with antibiotic therapy</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="form-group clearfix">
            <label style="float: left" class="h2" for="PrecautionsEn">2. What you need to know before you use this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p><strong>Do not take Ramep&trade; if you are</strong></p><p>- allergic to rabeprazole or any of the other ingredients of this medicine (listed in section 6)</p><p>- pregnant or think that you are pregnant</p><p>- breast-feeding.</p><p>Do not use Ramep&trade; if any of the above applies to you. If you are not sure, talk to</p><p>your doctor or pharmacist before using Ramep&trade;.</p><p><strong>Warnings and precautions</strong></p><p>Talk to your doctor or pharmacist before taking Ramep&trade;:</p><p>- If you are allergic to other proton pump inhibitors or &lsquo;substituted benzimidazoles&rsquo;</p><p>- If you have a stomach tumour.</p><p>- If you are on long-term treatment (longer than one year) you need to see your doctor at regular</p><p>intervals.</p><p>- If you have or had liver problems, you must tell your doctor. Your doctor may check your liver</p><p>function more often.</p><p>- If you are taking atazanavir (a medicine used to treat HIV) with these tablets is not recommended</p><p>(see section 2).</p><p>- If you have reduced body stores or risk factors for reduced vitamin B12 and receive long term</p><p>treatment with rabeprazole sodium. As with all acid reducing agents, rabeprazole sodium may lead</p><p>to a reduced absorption of vitamin B12.</p><p>- If you are due to have a specific blood test (Chromogranin A).</p><p>- If you have ever had a skin reaction after treatment with a medicine similar to Ramep&trade;: that reduces stomach acid.</p><p>- If you get a rash on your skin, especially in areas exposed to the sun tell your doctor as soon as you</p><p>can, as you may need to stop your treatment with Ramep&trade;. Remember to also</p><p>mention any other ill-effects like pain in your joints.</p><p>If you experience severe (watery or bloody) diarrhoea with symptoms such as fever, abdominal pain</p><p>or tenderness, stop taking Ramep&trade; and see a doctor straight away.</p><p>Taking a proton pump inhibitor like Ramep&trade;, especially over a period of more</p><p>than one year, may slightly increase your risk of fracture in the hip, wrist or spine. Tell your doctor if</p><p>you have osteoporosis or if you are taking corticosteroids (which can increase the risk of</p><p>osteoporosis).</p><p><strong>Children</strong></p><p>Ramep&trade; should not be used in children.</p><p><strong>Other medicines and Ramep&trade;</strong></p><p>Tell your doctor if you are taking, have recently taken or might take any other medicines.</p><p>Talk to your doctor before taking these tablets if you are already taking:</p><p>- ketoconazole or itraconazole (medicines used to treat fungal infections) &ndash; your dose may need to</p><p>be adjusted</p><p>- atazanavir (a medicine used to treat HIV) &ndash; Ramep&trade; may lower the amount of</p><p>this type of medicine in your blood and they should not be used together.</p><p>- methotrexate (a chemotherapy medicine used in high doses to treat cancer) &ndash; if you are taking a</p><p>high dose of methotrexate, your doctor may temporarily stop your Ramep&trade;</p><p>treatment</p><p>If you are not sure if any of the above applies to you, talk to your doctor or pharmacist before using</p><p>Ramep&trade;.</p><p><strong>Pregnancy and breast-feeding</strong></p><p>If you are pregnant or breast-feeding, think you may be pregnant or are planning to have a baby. Ask</p><p>your doctor or pharmacist for advice before taking any medicine. Do not take these tablets if you are</p><p>pregnant or are breast-feeding.</p><p><strong>Driving and using machines</strong></p><p>Usually Ramep&trade; does not affect the ability to drive and use machines. However,</p><p>this medicine may cause some patients to become sleepy. If you experience this side effect, you</p><p>should not drive or operate machinery.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="AdministrationRoutesEn">3. How to use this product.</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Always take this medicine exactly as your doctor has told you. Check with your doctor or pharmacist</p><p>if you are not sure.</p><p>If you are taking Ramep&trade; once a day, take the tablet before eating in morning.</p><p>Swallow the tablets whole. Do not crush or chew the tablets.</p><p><strong>Ulcers in the gut (duodenal ulcer)</strong></p><p>The usual dose is 20 mg once daily in the morning for 4 weeks. Your doctor may decide to prolong</p><p>the treatment for another 4 weeks.</p><p><strong>Ulcers in the stomach</strong></p><p>The usual dose is 20 mg once daily in the morning for 6 weeks. Your doctor may decide to prolong</p><p>the treatment for another 6 weeks.</p><p><strong>Erosive or ulcerative gastro-oesophageal reflux disease (GORD)</strong></p><p>The usual dose is 20 mg once daily for 4-8 weeks.</p><p><strong>Long-term treatment of gastro-oesophageal reflux disease (GORD)</strong></p><p>The usual maintenance dose is 10 mg or 20 mg once daily. If you are on long-term treatment you must</p><p>see your doctor at regular intervals for review of your tablets and symptoms.</p><p><strong>Relieving the symptoms of moderate to very severe gastro-oesophageal reflux disease (GORD)</strong></p><p>The usual dose is 10 mg once daily for 4 weeks.</p><p>If your symptoms do not resolve within 4 weeks consult your doctor. Following this initial 4 week</p><p>treatment, if your symptoms return, your doctor may then tell you to take one 10 mg tablet when</p><p>needed in order to control your symptoms.</p><p><strong>Severely increased acid secretion in the stomach (Zollinger-Ellison syndrome)</strong></p><p>The usual starting dose is 60 mg once daily. The dose may then be adjusted by your doctor depending</p><p>on how you respond to the treatment. Doses up to 60 mg twice daily may be given to you. Your</p><p>doctor will tell you how many tablets to take, when to take them and how long to take them.</p><p><strong>Treatment of infections caused by <em>H. pylori </em>when given in combination with antibiotic therapy</strong></p><p>The usual dose is 20 mg twice daily in combination with two antibiotics. The recommended</p><p>combination is:</p><p>Ramep&trade; 20 mg + clarithromycin 500 mg + amoxicillin 1 g, taken together twice</p><p>daily for 7 days.</p><p><strong>Renal and hepatic impairment</strong></p><p>Dose adjustment is not necessary.</p><p><strong>Use in children</strong></p><p>Do not give these tablets to children.</p><p><strong>If you take more Ramep&trade; than you should</strong></p><p>If you accidentally take more tablets than the prescribed dose, contact your doctor or nearest hospital</p><p>casualty department. Take this leaflet, any remaining tablets and the container with you to the doctor</p><p>or hospital so that they know what tablets were taken.</p><p><strong>If you forget to take Ramep&trade;</strong></p><p>It is important to take your medicine every day as regular treatment is more effective. However, if you</p><p>forget to take one or more doses, take another as soon as you remember and then go on as prescribed.</p><p>Do not take a double dose to make up for a forgotten dose.</p><p>If you have any further questions on the use of this product, ask your doctor or pharmacist.</p><p><strong>If you stop taking Ramep&trade;</strong></p><p>Relief of symptoms will normally occur before the ulcer has completely healed. <strong>It is important that</strong></p><p><strong>you do not stop taking the tablets until told to do so by your doctor.</strong></p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsEn">4. Possible side effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Like all medicines, this medicine can cause side effects, although not everybody gets them.</p><p><strong>Serious side effects</strong></p><p>You should contact your doctor <strong>immediately </strong>if you notice any of the following <strong>serious side effects</strong></p><p>(it may be <strong>an allergic reaction</strong>):</p><p><strong>Rare serious side effects </strong>(<strong>may affect up to 1 in 1,000 people</strong>)</p><p>&bull; swelling of the face, lips, tongue and throat which may cause difficulty in breathing, speaking</p><p>or swallowing, a sharp drop in blood pressure, pallor, fainting or collapse</p><p><strong>Very rare serious side effects </strong>(<strong>may affect up to 1 in 10,000 people</strong>)</p><p>&bull; blistering of the skin, and/or mucous membranes of the lips, eyes, mouth, nasal passages or</p><p>genitals (Steven-Johnson syndrome) or peeling off the skin (toxic epidermal necrolysis)</p><p><strong>Other possible side effects</strong></p><p><strong>Common side effects </strong>(may affect up to 1 in 10 people) are:</p><p>&bull; headache, dizziness</p><p>&bull; inability to sleep</p><p>&bull; cough, sore throat, runny and stuffy nose</p><p>&bull; diarrhoea, vomiting, feeling sick, stomach ache, constipation, wind (flatulence)</p><p>&bull; non-specific pain, back pain</p><p>&bull; infection</p><p>&bull; weakness, flu like illness</p><p>&bull; benign polyps in the stomach</p><p><strong>Uncommon side effects </strong>(may affect up to 1 in 100 people) are:</p><p>&bull; nervousness, drowsiness</p><p>&bull; cough with phlegm, chest pain and fever</p><p>&bull; feeling of pressure or pain in the cheeks and forehead</p><p>&bull; indigestion, dry mouth, belching</p><p>&bull; rash, skin reddening</p><p>&bull; muscle pain, leg cramps, joint pain</p><p>&bull; urinary tract infection</p><p>&bull; chest pain, chills, fever</p><p>&bull; increased liver enzymes</p><p>&bull; fracture of the hip, wrist or spine</p><p><strong>Rare side effects </strong>(may affect up to 1 in 1,000 people) are:</p><p>&bull; blood disorders which may lead to frequent infections, bleeding or bruising more easily than</p><p>normal or tiredness</p><p>&bull; loss of appetite (anorexia)</p><p>&bull; vision disturbances</p><p>&bull; gastritis, which might cause stomach pain and nausea</p><p>&bull; sore mouth</p><p>&bull; taste disturbances</p><p>&bull; liver disorder (hepatitis) which may make your skin or whites of the eyes yellow (jaundice)</p><p>&bull; liver failure leading to brain damage in patients who have previously had liver disease</p><p>&bull; itching and skin blisters: these usually disappear on stopping treatment</p><p>&bull; sweating</p><p>&bull; kidney problems which might cause high or low urine output</p><p>&bull; weight gain</p><p>&bull; depression</p><p>&bull; hypersensitivity (includes allergic reactions)</p><p><strong>Not known </strong>(frequency cannot be estimated from the available data)</p><p>&bull; low sodium levels in the blood</p><p>&bull; low magnesium levels in the blood*</p><p>&bull; confusion</p><p>&bull; breast enlargement in men</p><p>&bull; swelling of the ankles, feet or fingers</p><p>&bull; rash, possibly with pain in the joints</p><p>&bull; inflammation of the gut (leading to diarrhoea)</p><p>* If you are on Ramep&trade; for more than three months it is possible that the levels of</p><p>magnesium in your blood may fall. Low levels of magnesium can be seen as fatigue, involuntary</p><p>muscle contractions, disorientation, convulsions, dizziness, increased heart rate. If you get any of</p><p>these symptoms, please tell your doctor promptly. Low levels of magnesium can also lead to a</p><p>reduction in potassium or calcium levels in the blood. Your doctor may decide to perform regular</p><p>blood tests to monitor your levels of magnesium.</p><p><strong>Reporting of side effects</strong></p><p>If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects</p><p>not listed in this leaflet. By reporting side effects you can help provide more information on the safety</p><p>of this medicine.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsEn">5. How to store this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Keep this medicine out of the sight and reach of children.</p><p>Do not use this medicine after the expiry date which is stated on the tablet blister and carton after</p><p>EXP. The expiry date refers to the last day of that month.</p><p>Do not store above 30&deg;C. Store in the original package in order to protect from moisture.</p><p>Do not throw away any medicines via wastewater or household waste. Ask your pharmacist how to</p><p>throw away medicines you no longer use. These measures will help protect the environment.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. Further information</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsEn">a. What this product contains</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>The active substance is rabeprazole sodium.</p><p>Each 10 mg gastro-resistant tablet contains 10 mg rabeprazole sodium.</p><p>Each 20 mg gastro-resistant tablet contains 20 mg rabeprazole sodium.</p><p>The other ingredients are:</p><p>Tablet core: Calcium hydroxide, mannitol, low-substituted hydroxypropyl cellulose and sodium</p><p>stearyl fumarate.</p><p>Coating 1: Hypromellose, talc</p><p>Gastro-resistant coating 2 (10mg): Hypromellose phthalate, dibutyl sebacate, yellow ferric oxide</p><p>(E172), red ferric oxide (E172) and titanium dioxide (E171)</p><p>Gastro-resistant coating 2 (20mg): Hypromellose phthalate, dibutyl sebacate, yellow ferric oxide</p><p>(E172) and titanium dioxide (E171)</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsEn">b. What this product looks like and contents of the pack</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                Ramep™ 10 mg is a pink, round, biconvex, film-coated gastro-resistant tablet.
Ramep™ 20 mg is a yellow, round, biconvex, film-coated gastro-resistant tablet.
Al/Al blister with a desiccant:
AT/H/0260/001-002
5, 7, 10, 14, 15, 20, 25, 28, 30, 37, 50, 56, 60, 75, 90, 98, 100 and 120 gastro-resistant tablets
AT/H/0261/001-002
7, 10, 14, 20, 28, 30, 56, 60 and 98 gastro-resistant tablets
AT/H/0262/001-002
7, 10, 14, 15, 20, 28, 30, 37, 56, 60, 75, 98 and 120 gastro-resistant tablets
Not all pack sizes may be marketed.

            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingEn">c. Marketing Authorization Holder and Manufacturer</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p><strong>Marketing Authorisation Holder</strong></p><p>Sandoz GmbH, Biochemiestra&szlig;e 10</p><p>6250 - Kundl</p><p>Austria</p><p><strong>Manufacturer</strong></p><p>Lek Pharmaceuticals</p><p>d.d. Verovskova 57 SI-1526 Ljubljana,</p><p>SLOVENIA</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteEn">d. This leaflet was last revised in {MM/YYYY}</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                10/2017
            </div>
        </div>
    </div>
</div>    </div>
    <div id="A-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> نشرة الدواء تحت مراجعة الهيئة العامة للغذاء والدواء</span>
                <span style="font-size:small;">  (اقرأ هذه النشرة بعناية قبل البدء في استخدام هذا المنتج لأنه يحتوي على معلومات مهمة لك)</span>
            </div>
    <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr">

    </div>

</div>
<div class="clearfix rtl">
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="InventedNameAr">1. ما ھو هذا المستحضر وماھي دواعي استعماله</label>
        </div>
        <div class="form-group clearfix" style="float: right">
            <br />
            <p dir="RTL">&nbsp;</p><p dir="RTL">ينتمي رابيبرازول إلى مجموعة من الأدوية تُسمى &quot;مثبطات مضخة البروتون&quot;. تحد هذه الأدوية من إفراز الحمض في معدتك.</p><p dir="RTL">يُستخدم عقار راميب لعلاج الحالات التَّالية في البالغين:</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; قرح الأمعاء (تُسمى أيضًا قرح الإثنا عشر)</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; قرح المعدة (تُسمى أيضًا القرح الهضمية الحميدة)</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; تخفيف أعراض الحموضة (حُرْقَةُ الفُؤاد) النَّاجمة عن مرض الجَزْر (الارتجاع) المَعِدِيّ المَريئِيّ التآكلي أو التقرحي والذي يُسمى أيضًا الْتِهاب المَريءِ الجَزْرِيّ.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; العلاج طويل الأمد لمرض الجَزْر (الارتجاع) المَعِدِيّ المَريئِيّ لمنع حدوثه مجددًا.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; تخفيف أعراض مرض الجَزْر (الارتجاع) المَعِدِيّ المَريئِيّ المعتدل إلى الشديد جدًّا (مرض الجَزْر (الارتجاع) المَعِدِيّ المَريئِيّ المصحوب بأعراض) مثل الحموضة (حُرْقَة الفُؤاد) و ارتجاع الحمض &quot;القَلَس&quot;.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الارتفاع الشَّديد في إفراز الحمض بالمعدة (متلازمة زولينجر إليسون).</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; علاج العدوى النَّاجمة عن بكتيريا تُدعى <em>بكتيريا المَلْوِيَّة البَوَّابية </em>عند إعطائه بمصاحبة مضاد حيوي.</p><p dir="RTL">&nbsp;</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="PrecautionsAr">2. ما الذي يجب عليك معرفته قبل استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL"><strong>لا تتناول عقار راميب</strong><strong> </strong><strong>في الحالات الآتية</strong><strong>:</strong></p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; إذا كنت تعاني من حساسية تجاه رابيبرازول أو تجاه أي مكون من المكونات الأخرى بهذا الدَّواء (المدرجة في قسم: 6)</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; إذا كنتِ حاملًا أو كنتِ تعتقدين أنكِ حامل.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; إذا كنتِ تمارسين الرضاعة الطبيعيَّة</p><p dir="RTL">لا تستخدم عقار راميب إذا انطبق عليك أيٌّ مما سبق. إذا لم تكن متأكدًا، تحدَّث مع طبيبك أو الصيدلي الخاص بك قبل تناول عقار راميب</p><p dir="RTL"><strong>تحذيرات واحتياطات</strong></p><p dir="RTL">تحدَّث إلى طبيبك أو الصيدلي الخاص بك قبل تناوُل عقار راميب في الحالات التَّالية:</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; إذا كنت تعاني من حساسية تجاه مثبطات مضخات البروتون الأخرى أو &quot;البنزيميدازولات المستبدلة&quot;.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; إذا كان لديك ورم بالمعدة.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; إذا كنت تخضع لعلاج طويل الأمد (أكثر من عام واحد)، يتعين عليك زيارة طبيبك على فترات منتظمة.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; إذا كنت تعاني أو عانيت من مشاكل بالكبد، يجب عليك إخبار طبيبك. فقد يفحص طبيبك وظائف الكبد لديك على نحو أكثر تكرارًا.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; إذا كنت تتناول أتازانافير (دواء يُستخدم لعلاج فيروس نقص المناعة البشري) بمصاحبة هذه الأقراص؛ إذ لا يُوصى بذلك (انظر قسم: 2).</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; إذا كنت تعاني من انخفاض مخزون الجسم أو كان لديك عوامل خطورة لانخفاض مستويات فيتامين ب12<sub> </sub>وتتلقى علاجًا طويل الأمد برابيبرازول الصوديوم. كما هو الحال مع كافة الأدوية الخافضة للحمض، قد يُؤدي رابيبرازول الصوديوم إلى انخفاض امتصاص فيتامين ب12.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; إذا كنت بصدد الخضوع لإجراء اختبار معين بالدَّم (كروموجرانين &quot;أ&quot;).</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; إذا كنت قد أُصبت من قبل بتفاعل جلدي بعد العلاج بدواء مماثل لعقار راميب<strong>&trade;:</strong> الذي يقلل من حمض المعدة.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; إذا أُصبت بطفح جلدي، خاصَّة في المناطق المعرضة للشمس، فأخبر طبيبك في أقرب وقت ممكن؛ حيث قد تحتاج إلى إيقاف علاجك بعقار راميب. تذكر أيضًا ذكر أي آثار مرض أخرى مثل ألم بالمفاصل لديك.</p><p dir="RTL">إذا عانيت من إسهال شديد (مائي أو دموي) مصحوب بأعراض مثل الحمى أو ألم بالبطن أو وجع عند الضغط على البطن، فتوقف عن تناوُل عقار راميب&trade; وقم بزيارة طبيب على الفور.</p><p dir="RTL">إن تناول مثبط مضخة البروتون مثل عقار راميب&trade;، خاصَّة على مدى أكثر من عام واحد، قد يزيد من خطر الإصابة بكسور في الفخذ أو المعصم أو العمود الفقري بشكل طفيف. أخبر طبيبك إذا كنت مُصابًا بمرض هشاشة العظام أو إذا كنت تتناول الكورتيكوستيرويدات (التي يمكن أن تزيد من خطر الإصابة بهشاشة العظام).</p><p dir="RTL"><strong>الأطفال</strong></p><p dir="RTL">ينبغي عدم استخدام عقار راميب في الأطفال.</p><p dir="RTL"><strong>تناوُل أدوية أخرى مع عقار راميب</strong></p><p dir="RTL">يُرجى إبلاغ طبيبك إذا كنت تتناول أو تناولت مؤخرًا أو قد تتناول أيَّة أدوية أخرى.</p><p dir="RTL">تحدَّث إلى طبيبك قبل تناوُل هذه الأقراص إذا كنت بالفعل تتناول الآتي:</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; كيتوكونازول أو أتراكونازول (أدوية تُستخدم لعلاج<strong> </strong>العدوى الفطرية)&nbsp; &ndash; قد يتطلب الأمر ضبط جرعتك.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; أتازانافير (دواء يُستخدم لعلاج عدوى فيروس نقص المناعة البشرية)، قد يخفض عقار راميب&trade; من كمية هذا النوع من الدَّواء لديك بالدَّم وينبغي عدم استخدامهما معًا.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ميثوتركسات (دواء للعلاج الكيميائي يُستخدم بجرعات مرتفعة لعلاج السرطان) - إذا كنت تتناول جرعة مرتفعة من ميثوتريكسات، فقد يوقف طبيبك العلاج بعقار راميب&trade; بشكل مؤقت.</p><p dir="RTL">إذا لم تكن متأكدًا مما إذا كان أي مما سبق ينطبق عليك، فتحدَّث إلى طبيبك أو الصيدلي الخاص بك قبل استخدام عقار راميب.</p><p dir="RTL"><strong>الحمل والرَّضاعة الطبيعية</strong></p><p dir="RTL">إذا كنتِ حاملًا أو ترضعين، أو تعتقدين أنكِ قد تكونين حاملًا أو تخططين للحمل. استشيري طبيبك أو الصيدلي الخاص بك قبل تناول أي دواء. لا تتناولي هذه الأقراص إذا كنتِ حاملًا أو كنتِ تمارسين الرضاعة الطبيعيَّة.</p><p dir="RTL"><strong>القيادة واستخدام الآلات</strong></p><p>عادة ما لا يُؤثر عقار راميب في القدرة على ممارسة القيادة واستخدام الآلات. مع ذلك، قد يتسبب هذا الدَّواء في شعور بعض المرضى بالنعاس. إذا حدث لك ذلك الأثر الجانبي، فلا تمارس القيادة أو تشغل الآلات.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            https://localhost:44358/Dashboard
            <label class="h2" for="AdministrationRoutesAr">3. ماھي طريقة استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">تناول دائمًا هذا الدَّواء كما أخبرك طبيبك بالضبط. راجع طبيبك أو الصيدلي الخاص بك إذا لم تكن متأكدًا من كيفية الاستخدام.</p><p dir="RTL">إذا كنت تتناول عقار راميب&trade; مرة واحدة يوميًّا، تناول القرص قبل تناول الطعام صباحًا.</p><p dir="RTL">ابتلع القرص كاملًا. لا تسحق الأقراص أو تمضغها.</p><p dir="RTL"><strong>قرح الأمعاء </strong><strong>(</strong><strong>قرح الإثنا عشر</strong><strong>)</strong></p><p dir="RTL">تبلغ الجرعة المُعتادة 20 مجم مرَّة واحدة يوميًّا صباحًا لمدة 4 أسابيع. قد يقرر طبيبك مد فترة العلاج لمدة 4 أسابيع أخرى.</p><p dir="RTL"><strong>قرح المعدة</strong></p><p dir="RTL">تبلغ الجرعة المُعتادة 20 مجم مرَّة واحدة يوميًّا صباحًا لمدة 6 أسابيع. قد يقرر طبيبك مد فترة العلاج لمدة 6 أسابيع أخرى.</p><p dir="RTL"><strong>مرض الجَزْر </strong><strong>(</strong><strong>الارتجاع</strong><strong>) </strong><strong>المَعِدِيّ المَريئِيّ التآكلي أو التقرحي</strong></p><p dir="RTL">تبلغ الجرعة المُعتادة 20 مجم مرَّة واحدة يوميًّا لمدة تتراوح بين 4-8 أسابيع.</p><p dir="RTL"><strong>العلاج طويل الأمد لمرض الجَزْر </strong><strong>(</strong><strong>الارتجاع</strong><strong>) </strong><strong>المَعِدِيّ المَريئِيّ</strong></p><p dir="RTL">تبلغ جرعة المداومة المُعتادة 10 مجم أو 20 مجم مرَّة واحدة يوميًّا. إذا كنت تخضع لعلاج طويل الأمد، يجب عليك زيارة طبيبك على فترات منتظمة؛ للتَّحقق من أقراصك وفحص أعراضك.</p><p dir="RTL"><strong>تخفيف أعراض مرض الجَزْر </strong><strong>(</strong><strong>الارتجاع</strong><strong>) </strong><strong>المَعِدِيّ المَريئِيّ المعتدل إلى الشديد جدًّا</strong><strong>.</strong></p><p dir="RTL">تبلغ الجرعة المُعتادة 10 مجم مرَّة واحدة يوميًّا لمدة 4 أسابيع.</p><p dir="RTL">استشر طبيبك إذا لم تتلاشى الأعراض لديك في غضون 4 أسابيع. إذا عاودت أعراضك الظهور بعد الخضوع للعلاج الأولي لمدة 4 أسابيع، عندئذ قد يطلب منك طبيبك تناوُل قرص 10 مجم عند الضرورة للتحكم بأعراضك.</p><p dir="RTL"><strong>الارتفاع الشَّديد في إفراز الحمض بالمعدة </strong><strong>(</strong><strong>متلازمة زولينجر إليسون</strong><strong>).</strong></p><p dir="RTL">تبلغ جرعة البدء المُعتادة 60 مجم مرَّة واحدة يوميًّا. عندئذ، قد يعدل طبيبك الجرعة، وذلك وفقًا لكيفية استجابتك للعلاج.</p><p dir="RTL">&nbsp;قد يتم إعطاؤك جرعات تصل إلى 60 مجم مرتين يوميًّا. سيخبرك طبيبك بعدد الأقراص التي ستتناولها ومتى تتناولها ولأي مدة تتناولها.</p><p dir="RTL"><strong>علاج العدوى النَّاجمة عن <em>بكتيريا المَلْوِيَّة البَوَّابية </em>عند إعطائه بمصاحبة مضاد حيوي</strong><strong>.</strong></p><p dir="RTL">تبلغ الجرعة المُعتادة 20 مجم مرتين يوميًّا بمصاحبة مضادين حيويين. العلاج المصاحب المُوصى به هو:</p><p dir="RTL">عقار راميب&trade; 20 مجم + كلاريثروميسين 500 مجم + أموكسيسيلّين 1 جرام، يتم تناولها معًا مرتين يوميًّا لمدة 7 أيام.</p><p dir="RTL"><strong>قصور وظائف الكلى والكبد</strong></p><p dir="RTL">ليس من الضَّروري تعديل للجرعة.</p><p dir="RTL"><strong>الاستخدام في الأطفال</strong><strong>:</strong></p><p dir="RTL">لا تعطِ هذه الأقراص للأطفال.</p><p dir="RTL"><strong>إذا تناولت كمية أكثر مما يجب من عقار راميب</strong></p><p dir="RTL">إذا تناولت أقراصًا أكثر من الجرعة الموصوفة لك بطريق الخطأ، فاتصل بطبيبك أو قسم الطَّوارئ بأقرب مستشفى لك.</p><p dir="RTL">&nbsp;خذ معك هذه النَّشرة وما تبقى من الأقراص والعبوة للطبيب</p><p dir="RTL">أو للمستشفى حتى يكونوا على علم بالأقراص التي تم تناوُلها.</p><p dir="RTL"><strong>إذا أغفلت تناوُل عقار راميب</strong></p><p dir="RTL">من المهم أن تتناول دواءك كل يوم، فالعلاج المنتظم أكثر فعالية. مع ذلك، إذا نسيت تناول جرعة واحدة أو أكثر، فتناول جرعة أخرى بمجرد أن تتذكر ومن ثم استمر على النحو الموصوف.</p><p dir="RTL">&nbsp;</p><p dir="RTL">لا تتناول جرعة مضاعفة لتعويض جرعة أغفلتها.</p><p dir="RTL">إذا كانت لديك أية أسئلة إضافية حول استخدام هذا المنتج، فاستشر طبيبك أو الصيدلي.</p><p dir="RTL"><strong>إذا توقفت عن تناول عقار راميب</strong></p><p dir="RTL">عادة ما ستخف الأعراض قبل أن تُشفى القرح تمامًا. <strong>من المهم ألا تتوقف عن تناول هذه الأقراص حتى يطلب منك طبيبك ذلك</strong><strong>.</strong></p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsAr">4. الأعراض الجانبية المحتملة</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">مثله مثل كافة الأدوية، قد يُسبب هذا الدَّواء آثارًا جانبية، على الرَّغم من عدم حدوثها لدى الجميع.</p><p dir="RTL"><strong>الآثار الجانبية الخطيرة</strong></p><p dir="RTL"><strong>إذا لاحظت أيًّا من الآثار الجانبية الخطيرة التَّالية، فاتصل بطبيبك على الفور</strong><strong>:</strong></p><p dir="RTL">(قد يكون <strong>تفاعل حساسية</strong>):</p><p dir="RTL">الآثار الجانبية الخطيرة النَّادرة (قد تُؤثر على ما يصل إلى شخص واحد من بين كل 1000 شخص)</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; تورم الوجه، الشفتين، اللسان والحلق الذي قد يُسبب صعوبة في التَّنفس، التَّحدث أو البلع، انخفاض حاد في ضغط الدَّم، شحوب، إغماء أو هبوط.</p><p dir="RTL"><strong>الآثار الجانبية الخطيرة النَّادرة جدًّا،</strong> (قد تُؤثر على ما يصل إلى شخص واحد من بين كل 10.000&nbsp;شخص)</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ظهور بثور على الجلد، و/أو الأغشية المخاطية للشفتين، العينين، الفم، الممر الأنفي أو الأعضاء التَّناسلية (متلازمة ستيفن جونسون) أو تقشر الجلد (انحلال البشرة النخري التَّسَمُّمِيّ).</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;</p><p dir="RTL"><strong>الآثار الجانبية المحتملة الأخرى</strong></p><p dir="RTL">الآثار الجانبية الشَّائعة (قد تُؤثر على ما يصل إلى شخص واحد من بين كل 10&nbsp;أشخاص) هي:</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; صداع، دوخة.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; عدم القدرة على النوم.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; سعال، التهاب الحلق، سيلان الأنف وانسداده.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; إسهال، قيء، شعور بالإعياء، ألم بالمعدة، إمساك، ريح (انتفاخ البطن بالغازات).</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; آلام غير مُحددة، آلام الظهر.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; العدوى.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ضعف، مرض شبيه بنزلة البرد.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; سلائل حميدة بالمعدة.</p><p dir="RTL">الآثار الجانبية غير الشائعة (قد تُؤثر على ما يصل إلى شخص واحد من بين كل 100 شخص) هي:</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; عصبية، نعاس.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; سعال مصحوب ببلغم، ألم في الصدر وحُمى.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; شعور بضغط أو ألم في الخدين والجبهة.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; عسر الهضم، جُفاف الفَم، تجشؤ.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; طفح جلدي، احمرار الجلد.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ألم عضلي، تقلصات بالساق، ألم بالمفاصل.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; عدوى المسالك البولية.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ألم في الصدر، قشعريرة، حُمّى.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ارتفاع مستوى إنزيمات الكبد.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; كسر بالفخذ، المعصم أو العمود الفقري.</p><p dir="RTL">الآثار الجانبية النَّادرة (قد تُؤثر على ما يصل إلى شخص واحد من بين كل 1000 شخص) هي:</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; اضطرابات بالدَّم قد تُؤدي إلى الإصابة بعدوى متكررة، نزيف أو كدمات بسهولة أكثر من المُعتاد أو تعب.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; فقدان الشهية.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; اضطرابات الرؤية.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; التهاب المعدة الذي قد يسبب ألمًا بالمعدة وغثيان.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; التهاب الفَم.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; اضطرابات بحاسة التَّذوق.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; اضطرابات بالكبد (التهاب الكبد) تتسبب في اصفرار جلدك أو بياض عينيك (يرقان).</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; فشل الكبد مما يُؤدي إلى حدوث تلف بالمخ في المرضى الذين عانوا سابقًا من مرض بالكبد.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; حكة وبثور بالجلد: عادة ما تختفي عند وقف العلاج.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; تعرُّق.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; مشاكل بالكُلى قد تتسبب في ارتفاع أو انخفاض نتاج البول.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; زيادة الوزن.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; اكتئاب.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; فرط الحساسية (تشمل تفاعلات الحساسية)</p><p dir="RTL"><strong>غير معروفة </strong>(لا يمكن تقدير معدل التكرار من واقع البيانات المتاحة).</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; انخفاض مستويات الصوديوم في الدَّم.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; انخفاض مستويات الماغنسيوم في الدَّم*</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ارتباك.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; تضخم الثدي لدى الرجال.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; تورُّم الكاحلين، القدمين أو الأصابع.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; طفح جلدي، من المحتمل أن يكون مصحوبًا بألم في المفاصل.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; التهاب الأمعاء (مما يُؤدي إلى الإصابة بإسهال).</p><p dir="RTL">إذا كنت تتناول عقار راميب لأكثر من ثلاثة أشهر، فمن المحتمل أن تنخفض مستويات الماغنسيوم لديك في الدَّم. من الممكن ملاحظة انخفاض مستويات الماغنسيوم على شكل إرهاق وانقباضات عضلية غير إرادية وتوهان وتشنجات ودوخة وزيادة معدل ضربات القلب.</p><p dir="RTL">. اذا أصبت بأيٍّ من هذه الأعراض، فيرجى إخبار طبيبك فورًا. من الممكن أن يُؤدي انخفاض مستويات الماغنسيوم أيضًا إلى انخفاض مستويات البوتاسيوم أو الكالسيوم في الدَّم. قد يقرر طبيبك إجراء اختبارات دم منتظمة؛ لمراقبة مستويات الماغنسيوم لديك.</p><p dir="RTL"><strong>الإبلاغ عن الآثار الجانبية</strong></p><p dir="RTL">إذا ظهرت لديك أية آثار جانبية، فتحدَّث إلى الطبيب أو الصيدلي الخاص بك. ويشمل ذلك أية آثار جانبية مُحتمَلة، غير المُدرجة في هذه النَّشرة. بإبلاغك عن الآثار الجانبية، يمكنك المساعدة في توفير المزيد من المعلومات حول أمان استخدام هذا الدَّواء.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsAr">5. طريقة تخزين المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">يُحفظ هذا الدَّواء بعيدًا عن رؤية ومُتناوَل الأطفال.</p><p dir="RTL">لا تستعمل هذا الدَّواء بعد انتهاء تاريخ الصلاحية المدون على شريط الأقراص والعبوة الكرتونية بعد كلمة</p><p dir="RTL">&quot;EXP&quot;. يُشير تاريخ انتهاء الصَّلاحية إلى اليوم الأخير من ذلك الشهر.</p><p dir="RTL">لا تقم بالتَّخزين في درجة حرارة تتعدى 30 درجة مئوية. يخزن في العبوة الأصلية للحماية من الرطوبة.</p><p dir="RTL">لا تتخلص من أي أدوية عن طريق إلقائها في مياه الصَّرف أو مع المخلفات المنزلية. استشر الصيدلي الخاص بك عن كيفية التَّخلص من الأدوية التي لم تَعُد تستخدمها. ستُساعد هذه الإجراءات في الحفاظ على البيئة.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: right">6. معلومات أخرى</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsAr">أ‌. على ماذا يحتوي هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">المادة الفعالة هي رابيبرازول الصوديوم</p><p dir="RTL">يحتوي كل قرص مقاوم لإفرازات المعدة 10 مجم على 10 مجم من رابيبرازول الصوديوم.</p><p dir="RTL">يحتوي كل قرص مقاوم لإفرازات المعدة 20 مجم على 20 مجم من رابيبرازول الصوديوم.</p><p dir="RTL">المكونات الأخرى هي:</p><p dir="RTL">محتوى القرص الدَّاخلي: هيدروكسيد الكالسيوم، مانيتول، هيدروكسي بروبيل السليلوز منخفض الاستبدال وفومارات ستيريل الصوديوم.</p><p dir="RTL">الغلاف الخارجي الأول: هيبروميلوز، تلك الغلاف الخارجي الثاني المقاوم لإفرازات المعدة (10 مجم): هيبروميلوز فثالات، سيباكيت ثنائي البيوتيل، أُكسيد الحَدِيْدِيْك الأصفر (E172) أُكسيد الحَدِيْدِيْك الأحمر (E172) وثاني أكسيد التيتانيوم (E171).</p><p dir="RTL">&nbsp;</p><p dir="RTL">الغلاف الخارجي الثاني المقاوم لإفرازات المعدة (20 مجم): هيبروميلوز فثالات، سيباكيت ثنائي البيوتيل، أُكسيد الحَدِيْدِيْك الأصفر (E172) وثاني أكسيد التيتانيوم (E171).</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsAr">ب‌. كيف يبدو شكل هذا المستحضر وماهي محتويات العلبة</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">عقار راميب&trade; 10 مجم هو قرص وردي، دائري، ثنائي التحدُّب ومُغلف بغلاف مقاوم لإفرازات المعدة.</p><p dir="RTL">عقار راميب&trade; 20 مجم هو قرص أصفر، دائري، ثنائي التحدُّب ومُغلف بغلاف مقاوم لإفرازات المعدة.</p><p dir="RTL">شريط من الألومنيوم/ الألومنيوم مع مادة مُجفِّفة:</p><p dir="RTL">AT/H/0260/001-002</p><p dir="RTL">5، 7، 10، 14، 15، 20، 25، 28، 30، 37، 50، 56، 60، 75، 90، 98، 100 و 120 قرصًا مقاومًا لإفرازات المعدة.</p><p dir="RTL">AT/H/0261/001-002</p><p dir="RTL">7، 10، 14، 20، 28، 30، 56، 60 و 98 قرصًا مقاومًا لإفرازات المعدة.</p><p dir="RTL">AT/H/0262/001-002</p><p dir="RTL">7، 10، 14، 15، 20، 28، 30، 37، 56، 60، 75، 98 و 120 قرصًا مقاومًا لإفرازات المعدة.</p><p dir="RTL">قد لا يتم تسويق جميع أحجام العبوات.</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingAr">ت‌. الشركة المصنعة ومالك حق التسويق</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL"><strong>مالك حق التَّسويق</strong></p><p dir="RTL">شركة ساندوز المحدودة، 10 بايوكيمستيراب</p><p dir="RTL">6250 - كوندل</p><p dir="RTL">النمسا</p><p dir="RTL"><strong>جهة التَّصنيع</strong></p><p dir="RTL">شركة ليك للصناعات الدَّوائية شركة مساهمة</p><p dir="RTL">&nbsp;فيروفسكوفا<em> </em>57 SI-1526<em> </em>ليوبليانا،</p><p dir="RTL">سلوفينيا</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteAr">ث‌. تمت مراجعة هذه النشرة في التاريخ الذي تمت فيه مراجعة النشرة بالشهر والسنة</label>
        </div>
        <div class="m-r-60">
            10/2017
        </div>
    </div>
</div>
    </div>
    <div id="M-div" class="box-data">


    <div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr"><i class="fa fa-info-circle"></i>&nbsp;Read this leaflet carefully before you start using this product as it contains important information for you</div>
    </div>
<div class="row clearfix ltr">

    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="MedicinalName">1. NAME OF THE MEDICINAL PRODUCT </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Ramep™, 10 mg, gastro-resistant tablets
Ramep™, 20 mg, gastro-resistant tablets

            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="QualitativeQuantitativeComposition">2. QUALITATIVE AND QUANTITATIVE COMPOSITION </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Ramep™ 10 mg:
Each gastro-resistant tablet contains 10 mg rabeprazole sodium.
Ramep™ 20 mg:
Each gastro-resistant tablet contains 20 mg rabeprazole sodium.
For the full list of excipients, see section 6.1

            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="DosageForm">3. PHARMACEUTICAL FORM </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Gastro-resistant tablet.
Ramep™ 10 mg:
pink, round, biconvex, film-coated gastro-resistant tablet.
Ramep™ name 20 mg:
yellow, round, biconvex, film-coated gastro-resistant tablet.

            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">4. CLINICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="TherapeuticIndications">4.1 Therapeutic Indications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Ramep&trade; is indicated for the treatment of:</p><p>&bull; Active duodenal ulcer</p><p>&bull; Active benign gastric ulcer</p><p>&bull; Symptomatic erosive or ulcerative gastro-oesophageal reflux disease (GORD)</p><p>&bull; Gastro-Oesophageal Reflux Disease Long-term Management (GORD Maintenance)</p><p>&bull; Symptomatic treatment of moderate to very severe gastro-oesophageal reflux disease (symptomatic</p><p>GORD)</p><p>&bull; Zollinger-Ellison Syndrome</p><p>&bull; In combination with appropriate antibacterial therapeutic regimens for the eradication of</p><p><em>Helicobacter pylori </em>in patients with peptic ulcer disease. See section 4.2.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PosologyAndMethodAdministration">4.2 Posology And Method Administration</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Posology</p><p>Adults/elderly</p><p><em>Active Duodenal Ulcer and Active Benign Gastric Ulcer: </em>The recommended oral dose for both active</p><p>duodenal ulcer and active benign gastric ulcer is 20 mg to be taken once daily in the morning.</p><p>Most patients with active duodenal ulcer heal within four weeks. However a few patients may require</p><p>an additional four weeks of therapy to achieve healing. Most patients with active benign gastric ulcer</p><p>heal within six weeks. However again a few patients may require an additional six weeks of therapy</p><p>to achieve healing.</p><p><em>Erosive or Ulcerative Gastro-Oesophageal Reflux Disease (GORD): </em>The recommended oral dose for</p><p>this condition is 20 mg to be taken once daily for four to eight weeks.</p><p><em>Gastro-Oesophageal Reflux Disease Long-term Management (GORD Maintenance)</em>: For long-term</p><p>management, a maintenance dose of Ramep&trade; 20 mg or 10 mg once daily can be</p><p>used depending upon patient response.</p><p><em>Symptomatic treatment of moderate to very severe gastro-oesophageal reflux disease (symptomatic</em></p><p><em>GORD): </em>10 mg once daily in patients without oesophagitis. If symptom control has not been achieved</p><p>during four weeks, the patient should be further investigated. Once symptoms have resolved,</p><p>subsequent symptom control can be achieved using an on-demand regimen taking 10 mg once daily</p><p>when needed.</p><p><em>Zollinger-Ellison Syndrome: </em>The recommended adult starting dose is 60 mg once a day. The dose</p><p>may be titrated upwards to 120 mg/day based on individual patient needs. Single daily doses up to</p><p>100 mg/day may be given. 120 mg dose may require divided doses, 60 mg twice daily. Treatment</p><p>should continue for as long as clinically indicated.</p><p><em>Eradication of H. pylori: </em>Patients with <em>H. pylori </em>infection should be treated with eradication therapy.</p><p>The following combination given for 7 days is recommended.</p><p>Ramep&trade; 20 mg twice daily + clarithromycin 500 mg twice daily and amoxicillin</p><p>1 g twice daily.</p><p>Renal and hepatic impairment</p><p>No dosage adjustment is necessary for patients with renal or hepatic impairment.</p><p>See section 4.4 Special Warnings and Precautions for Use of Ramep&trade; in the</p><p>treatment of patients with severe hepatic impairment.</p><p>Paediatric population</p><p>Ramep&trade; is not recommended for use in children, as there is no experience of its</p><p>use in this group.</p><p>Method of administration</p><p>For indications requiring once daily treatment Ramep&trade; tablets should be taken in</p><p>the morning, before eating; and although neither the time of day nor food intake was shown to have</p><p>any effect on rabeprazole sodium activity, this regimen will facilitate treatment compliance.</p><p>Patients should be cautioned that the Ramep&trade; tablets should not be chewed or</p><p>crushed, but should be swallowed whole.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Contraindications">4.3 Contraindications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Ramep™ is contra-indicated in patients with known hypersensitivity to the active
substance or to any of the excipients listed in section 6.1.
Ramep™ is contra-indicated in pregnancy and during breast-feeding.

            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialWarnings">4.4. Special warnings and precautions for use</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><strong>4.4 Special warnings and precautions for use</strong></p><p>Symptomatic response to therapy with rabeprazole sodium does not preclude the presence of gastric</p><p>or oesophageal malignancy, therefore the possibility of malignancy should be excluded prior to</p><p>commencing treatment with Ramep&trade;.</p><p>Patients on long-term treatment (particularly those treated for more than a year) should be kept under</p><p>regular surveillance.</p><p>A risk of cross-hypersensitivity reactions with other proton pump inhibitor or substituted</p><p>benzimidazoles cannot be excluded.</p><p>Patients should be cautioned that Ramep&trade; tablets should not be chewed or</p><p>crushed, but should be swallowed whole.</p><p>There have been post marketing reports of blood dyscrasias (thrombocytopaenia and neutropaenia). In</p><p>the majority of cases where an alternative aetiology cannot be identified, the events were</p><p>uncomplicated and resolved on discontinuation of rabeprazole.</p><p>Hepatic enzyme abnormalities have been seen in clinical trials and have also been reported since</p><p>market authorization. In the majority of cases where an alternative aetiology cannot be identified, the</p><p>events were uncomplicated and resolved on discontinuation of rabeprazole. No evidence of significant</p><p>medicinal product related safety problems was seen in a study of patients with mild to moderate</p><p>hepatic impairment versus normal age and sex matched controls. However because there are no</p><p>clinical data on the use of Ramep&trade; in the treatment of patients with severe</p><p>hepatic dysfunction the prescriber is advised to exercise caution when treatment with Ramep&trade;</p><p>&nbsp;is first initiated in such patients.</p><p>Co-administration of atazanavir with Ramep&trade; is not recommended (see section</p><p>4.5).</p><p>Treatment with proton pump inhibitors, including Ramep&trade;, may possibly</p><p>increase the risk of gastrointestinal infections such as <em>Salmonella, Campylobacter </em>and <em>Clostridium</em></p><p><em>difficile </em>(see section 5.1).</p><p>Proton pump inhibitors, especially if used in high doses and over long durations (&gt;1 year), may</p><p>modestly increase the risk of hip, wrist and spine fracture, predominantly in the elderly or in presence</p><p>of other recognised risk factors. Observational studies suggest that proton pump inhibitors may</p><p>increase the overall risk of fracture by 10&ndash;40%. Some of this increase may be due to other risk</p><p>factors. Patients at risk of osteoporosis should receive care according to current clinical guidelines</p><p>and they should have an adequate intake of vitamin D and calcium.</p><p>Hypomagnesaemia</p><p>Severe hypomagnesaemia has been reported in patients treated with proton pump inhibitors (PPIs)</p><p>like rabeprazole sodium for at least three months, and in most cases for a year. Serious manifestations</p><p>of hypomagnesaemia such as fatigue, tetany, delirium, convulsions, dizziness and ventricular</p><p>arrhythmia can occur but may begin insidiously and be overlooked. In most affected patients,</p><p>hypomagnesaemia improved after magnesium replacement and discontinuation of the PPI.</p><p>For patients expected to be on prolonged treatment or who take PPIs with medicinal products or drugs</p><p>that may cause hypomagnesaemia (e.g. diuretics), health care professionals should consider</p><p>measuring magnesium levels before starting PPI treatment and periodically during treatment.</p><p>Concomitant use of Rabeprazole with Methotrexate</p><p>Literature suggests that concomitant use of PPIs with methotrexate (primarily at high dose; see</p><p>methotrexate prescribing information) may elevate and prolong serum levels of methotrexate and/or</p><p>its metabolite, possibly leading to methotrexate toxicities. In high-dose methotrexate administration, a</p><p>temporary withdrawal of the PPI may be considered in some patients.</p><p>Influence on vitamin B12 absorption</p><p>Rabeprazole sodium, as all acid-blocking medicines, may reduce the absorption of vitamin B12</p><p>(cyanocobalamin) due to hypo- or a- chlorhydria. This should be considered in patients with reduced</p><p>body stores or risk factors for reduced vitamin B12 absorption on long-term therapy or if respective</p><p>clinical symptoms are observed.</p><p>Subacute cutaneous lupus erythematosus (SCLE)</p><p>Proton pump inhibitors are associated with very infrequent cases of SCLE. If lesions occur, especially</p><p>in sun-exposed areas of the skin, and if accompanied by arthralgia, the patient should seek medical</p><p>help promptly and the health care professional should consider stopping Ramep&trade;.</p><p>SCLE after previous treatment with a proton pump inhibitor may increase the risk of SCLE with other</p><p>proton pump inhibitors.</p><p>Interference with laboratory tests</p><p>Increased Chromogranin A (CgA) level may interfere with investigations for neuroendocrine tumours.</p><p>To avoid this interference, Ramep&trade; treatment should be stopped for at least 5</p><p>days before CgA measurements (see section 5.1). If CgA and gastrin levels have not returned to</p><p>reference range after initial measurement, measurements should be repeated 14 days after cessation of</p><p>proton pump inhibitor treatment.</p><p>Paediatric population</p><p>&nbsp;Ramep&trade; is not recommended for use in children, as there is no experience of its</p><p>use in this group.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="InteractionsOtherMedicines">4.5. Interactions with other medicinal products</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Rabeprazole sodium produces a profound and long lasting inhibition of gastric acid secretion. An</p><p>interaction with compounds whose absorption is pH dependent may occur. Co-administration of</p><p>rabeprazole sodium with ketoconazole or itraconazole may result in a significant decrease in</p><p>antifungal plasma levels. Therefore individual patients may need to be monitored to determine if a</p><p>dosage adjustment is necessary when ketoconazole or itraconazole are taken concomitantly with</p><p>Ramep&trade;.</p><p>In clinical trials, antacids were used concomitantly with the administration of rabeprazole and, in a</p><p>specific drug-drug interaction study, no interaction with liquid antacids was observed.</p><p>Co-administration of atazanavir 300 mg/ritonavir 100 mg with omeprazole (40 mg once daily) or</p><p>atazanavir 400 mg with lansoprazole (60 mg once daily) to healthy volunteers resulted in a substantial</p><p>reduction in atazanavir exposure. The absorption of atazanavir is pH dependent. Although not studied,</p><p>similar results are expected with other proton pump inhibitors. Therefore PPIs, including rabeprazole,</p><p>should not be co-administered with atazanavir (see section 4.4).</p><p>Methotrexate</p><p>Case reports, published population pharmacokinetic studies, and retrospective analyses suggest that</p><p>concomitant administration of PPIs and methotrexate (primarily at high dose; see methotrexate</p><p>prescribing information) may elevate and prolong serum levels of methotrexate and/or its metabolite</p><p>hydroxymethotrexate. However, no formal medicinal product interaction studies of methotrexate with</p><p>PPIs have been conducted.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="FertilityAndPregnantWarnings">4.6. Fertility, pregnancy and lactation</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Pregnancy</p><p>There are no data on the safety of rabeprazole in human pregnancy. Reproduction studies performed</p><p>in rats and rabbits have revealed no evidence of impaired fertility or harm to the foetus due to</p><p>rabeprazole sodium, although low foeto-placental transfer occurs in rats. Ramep&trade;</p><p>is contraindicated during pregnancy.</p><p>Breast-feeding</p><p>It is not known whether rabeprazole sodium is excreted in human breast milk. No studies in breastfeeding</p><p>women have been performed. Rabeprazole sodium is however excreted in rat mammary</p><p>secretions. Therefore Ramep&trade; must not be used during breast-feeding.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="EffectsAbilityDriveMachines">4.7. Effects on ability to drive and use machines</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Based on the pharmacodynamic properties and the adverse events profile, it is unlikely that</p><p>Ramep&trade; would cause an impairment of driving performance or compromise the ability to use machinery. If however, alertness is impaired due to somnolence, it is recommended that</p><p>driving and operating complex machinery be avoided.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="UndesirableEffects">4.8. Undesirable effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>The most commonly reported adverse reactions, during controlled clinical trials with rabeprazole</p><p>were headache, diarrhoea, abdominal pain, asthenia, flatulence, rash and dry mouth. The majority of</p><p>adverse events experienced during clinical studies were mild or moderate in severity, and transient in</p><p>nature.</p><p>The following adverse events have been reported from clinical trial and post-marketing experience.</p><p>Frequencies are defined as: common (&ge; 1/100, &lt; 1/10), uncommon (&ge; 1/1,000, &lt; 1/100), rare</p><p>(&ge;1/10,000, &lt;1/1,000) and very rare (&lt; 1/10,000). Not known (cannot be estimated from the available</p><p>data).</p><p>Infections and infestations</p><p>Common: infection</p><p>Blood and the lymphatic system disorders</p><p>Rare: neutropenia, leucopenia, thrombocytopenia, leucocytosis</p><p>Immune system disorders</p><p>Rare: hypersensitivity1,2</p><p>Metabolism and nutrition disorders</p><p>Rare: anorexia</p><p>Not known: hyponatraemia, hypomagnesaemia (see section 4.4).</p><p>Psychiatric disorders</p><p>Common: insomnia</p><p>Uncommon: nervousness</p><p>Rare: depression</p><p>Not known: Confusion</p><p>Nervous system disorders</p><p>Common: headache, dizziness</p><p>Uncommon: somnolence</p><p>Eye disorders</p><p>Rare: visual disturbance</p><p>Vascular disorders</p><p>Not known: peripheral oedema</p><p>Respiratory, thoracic and mediastinal disorders:</p><p>Common: cough, pharyngitis, rhinitis</p><p>Uncommon: bronchitis, sinusitis</p><p>Gastrointestinal disorders</p><p>Common: diarrhoea, vomiting, nausea, abdominal pain, constipation, flatulence, fundic gland polyps</p><p>(benign)</p><p>Uncommon: dyspepsia, dry mouth, eructation</p><p>Rare: gastritis, stomatitis, taste disturbance</p><p>Not known: microscopic colitis</p><p>Hepatobiliary disorders</p><p>Rare: hepatitis, jaundice, hepatic encephalopathy3</p><p>Skin and subcutaneous tissue disorders</p><p>Uncommon: rash, erythema2</p><p>Rare: pruritus, sweating, bullous reactions2</p><p>Very rare: erythema multiforme, Stevens-Johnson syndrome (SJS), toxic epidermal necrolysis (TEN)</p><p>Not known: Subacute cutaneous lupus erythematosus (see section 4.4)</p><p>Musculoskeletal, connective tissue and bone disorders</p><p>Common: non-specific pain, back pain</p><p>Uncommon: myalgia, leg cramps, arthralgia, fracture of the hip, wrist or spine (see section 4.4).</p><p>Renal and urinary disorders</p><p>Uncommon: urinary tract infection</p><p>Rare: interstitial nephritis</p><p>Reproductive system and breast disorders</p><p>Not known: gynaecomastia</p><p>General disorders and administration site conditions:</p><p>Common: asthenia, influenza like illness</p><p>Uncommon: chest pain, chills, pyrexia</p><p>Investigations:</p><p>Uncommon: increased hepatic enzymes3</p><p>Rare: weight increased</p><p>1 Includes facial swelling, hypotension and dyspnoea</p><p>2 Erythema, bullous reactions and hypersensitivity reactions have usually resolved after</p><p>discontinuation of therapy.</p><p>3 Rare reports of hepatic encephalopathy have been received in patients with underlying cirrhosis. In</p><p>treatment of patients with severe hepatic dysfunction the prescriber is advised to exercise caution</p><p>when treatment with [Ramep&trade;] is first initiated in such patients (see section 4.4).</p><p>Reporting of suspected adverse reactions</p><p>Reporting suspected adverse reactions after authorisation of the medicinal product is important. It</p><p>allows continued monitoring of the benefit/risk balance of the medicinal product. Healthcare</p><p>professionals are asked to report any suspected adverse reactions via the national reporting system</p><p>listed in Appendix V.</p><p>&nbsp;</p><p>To reports any side effect(s):</p><p>&nbsp;&nbsp; <strong>Saudi Arabia:</strong></p><table border="1" cellspacing="0" cellpadding="0"><tbody><tr><td style="vertical-align:top"><p>&bull;&nbsp;&nbsp;&nbsp; The National Pharmacovigilance Centre (NPC):</p><p>-&nbsp;&nbsp;&nbsp; Fax: +966-11-205-7662</p><p>-&nbsp;&nbsp;&nbsp; Call NPC at +966-11-2038222, Ext 2317-2356-2340</p><p>-&nbsp;&nbsp;&nbsp; SFDA Call Center: 19999</p><p>-&nbsp;&nbsp;&nbsp; E-mail: npc.drug@sfda.gov.sa</p><p>-&nbsp;&nbsp;&nbsp; Website: https://ade.sfda.gov.sa/</p></td></tr></tbody></table><p>&nbsp;</p><p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <strong>Other GCC States:</strong></p><table border="1" cellspacing="0" cellpadding="0"><tbody><tr><td style="vertical-align:top"><p>-&nbsp;&nbsp;&nbsp; Please contact the relevant competent authority.</p></td></tr></tbody></table>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Overdoes">4.9. Overdoes</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Experience to date with deliberate or accidental overdose is limited. The maximum established</p><p>exposure has not exceeded 60 mg twice daily, or 160 mg once daily. Effects are generally minimal,</p><p>representative of the known adverse event profile and reversible without further medical intervention.</p><p>No specific antidote is known. Rabeprazole sodium is extensively protein bound and is, therefore, not</p><p>dialyzable. As in any case of overdose, treatment should be symptomatic and general supportive</p><p>measures should be utilised.</p>
            </div>
        </div>
    </div>

    <div class="col-xs-12">
        <label style="float: left">5. PHARMACOLOGICAL PROPERTIES</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PharmacodynamicProperties">5.1. Pharmacodynamic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Pharmacotherapeutic group: Alimentary tract and metabolism, drugs for peptic ulcer and gastro</p><p>oesophageal reflux disease (GORD), proton pump inhibitors, ATC code: A02B C04</p><p><em>Mechanism of Action</em></p><p>Rabeprazole sodium belongs to the class of anti-secretory compounds, the substituted benzimidazoles,</p><p>that do not exhibit anticholinergic or H2 histamine antagonist properties, but suppress gastric acid</p><p>secretion by the specific inhibition of the H+/K+-ATPase enzyme (the acid or proton pump). The</p><p>effect is dose-related and leads to inhibition of both basal and stimulated acid secretion irrespective of</p><p>the stimulus. Animal studies indicate that after administration, rabeprazole sodium rapidly disappears</p><p>from both the plasma and gastric mucosa. As a weak base, rabeprazole is rapidly absorbed following</p><p>all doses and is concentrated in the acid environment of the parietal cells. Rabeprazole is converted to</p><p>the active sulphenamide form through protonation and it subsequently reacts with the available</p><p>cysteines on the proton pump.</p><p><em>Anti-secretory Activity</em></p><p>After oral administration of a 20 mg dose of rabeprazole sodium the onset of the anti-secretory effect</p><p>occurs within one hour, with the maximum effect occurring within two to four hours. Inhibition of</p><p>basal and food stimulated acid secretion 23 hours after the first dose of rabeprazole sodium are 69%</p><p>and 82% respectively and the duration of inhibition lasts up to 48 hours. The inhibitory effect of</p><p>rabeprazole sodium on acid secretion increases slightly with repeated once-daily dosing, achieving</p><p>steady state inhibition after three days. When the medicinal product is discontinued, secretory activity</p><p>normalises over 2 to 3 days.</p><p>Decreased gastric acidity due to any means, including proton pump inhibitors such as rabeprazole,</p><p>increases counts of bacteria normally present in the gastrointestinal tract. Treatment with proton</p><p>pump inhibitors, including Ramep&trade;, may possibly increase the risk of</p><p>gastrointestinal infections such as <em>Salmonella</em>, <em>Campylobacter </em>and <em>Clostridium difficile</em>.</p><p><em>Serum Gastrin Effects</em></p><p>In clinical studies patients were treated once daily with 10 or 20 mg rabeprazole sodium, for up to 43</p><p>months duration. Serum gastrin levels increased during the first 2 to 8 weeks reflecting the inhibitory</p><p>effects on acid secretion and remained stable while treatment was continued. Gastrin values returned</p><p>to pre-treatment levels, usually within 1 to 2 weeks after discontinuation of therapy.</p><p>Human gastric biopsy specimens from the antrum and the fundus from over 500 patients receiving</p><p>rabeprazole or comparator treatment for up to 8 weeks have not detected changes in ECL cell</p><p>histology, degree of gastritis, incidence of atrophic gastritis, intestinal metaplasia or distribution of <em>H.</em></p><p><em>pylori </em>infection. In over 250 patients followed for 36 months of continuous therapy, no significant</p><p>change in findings present at baseline was observed.</p><p><em>Other Effects</em></p><p>Systemic effects of rabeprazole sodium in the CNS, cardiovascular and respiratory systems have not</p><p>been found to date. Rabeprazole sodium, given in oral doses of 20 mg for 2 weeks, had no effect on</p><p>thyroid function, carbohydrate metabolism, or circulating levels of parathyroid hormone, cortisol,</p><p>oestrogen, testosterone, prolactin, cholecystokinin, secretin, glucagon, follicle stimulating hormone</p><p>(FSH), luteinising hormone (LH), renin, aldosterone or somatotrophic hormone.</p><p>Studies in healthy subjects have shown that rabeprazole sodium does not have clinically significant</p><p>interactions with amoxicillin. Rabeprazole does not adversely influence plasma concentrations of</p><p>amoxicillin or clarithromycin when co-administered for the purpose of eradicating upper</p><p>gastrointestinal <em>H. pylori </em>infection.</p><p>During treatment with antisecretory medicinal products, serum gastrin increases in response to the</p><p>decreased acid secretion. Also CgA increases due to decreased gastric acidity. The increased CgA</p><p>level may interfere with investigations for neuroendocrine tumours.</p><p>Available published evidence suggests that proton pump inhibitors should be discontinued between 5</p><p>days and 2 weeks prior to CgA measurements. This is to allow CgA levels that might be spuriously</p><p>elevated following PPI treatment to return to reference range.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
                <label style="float: left" for="PharmacokineticProperties">5.2. Pharmacokinetic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><em>Absorption</em></p><p>Ramep&trade; is an enteric-coated (gastro-resistant) tablet formulation of rabeprazole</p><p>sodium. This presentation is necessary because rabeprazole is acid-labile. Absorption of rabeprazole</p><p>therefore begins only after the tablet leaves the stomach. Absorption is rapid, with peak plasma levels</p><p>of rabeprazole occurring approximately 3.5 hours after a 20 mg dose. Peak plasma concentrations</p><p>(Cmax) of rabeprazole and AUC are linear over the dose range of 10 mg to 40 mg. Absolute</p><p>bioavailability of an oral 20 mg dose (compared to intravenous administration) is about 52% due in</p><p>large part to pre-systemic metabolism. Additionally the bioavailability does not appear to increase</p><p>with repeat administration. In healthy subjects the plasma half-life is approximately one hour (range</p><p>0.7 to 1.5 hours), and the total body clearance is estimated to be 283 &plusmn; 98 ml/min. There was no</p><p>clinically relevant interaction with food. Neither food nor the time of day of administration of the</p><p>treatment affect the absorption of rabeprazole sodium.</p><p><em>Distribution</em></p><p>Rabeprazole is approximately 97% bound to human plasma proteins.</p><p><em>Biotransformation and elimination</em></p><p>Rabeprazole sodium, as is the case with other members of the proton pump inhibitor (PPI) class of</p><p>compounds, is metabolised through the cytochrome P450 (CYP450) hepatic drug metabolising</p><p>system. <em>In vitro </em>studies with human liver microsomes indicated that rabeprazole sodium is</p><p>metabolised by isoenzymes of CYP450 (CYP2C19 and CYP3A4). In these studies, at expected human</p><p>plasma concentrations rabeprazole neither induces nor inhibits CYP3A4; and although <em>in vitro </em>studies</p><p>may not always be predictive of <em>in vivo </em>status these findings indicate that no interaction is expected</p><p>between rabeprazole and cyclosporine. In humans the thioether (M1) and carboxylic acid (M6) are the</p><p>main plasma metabolites with the sulphone (M2), desmethyl-thioether (M4) and mercapturic acid</p><p>conjugate (M5) minor metabolites observed at lower levels. Only the desmethyl metabolite (M3) has</p><p>a small amount of anti-secretory activity, but it is not present in plasma.</p><p>Following a single 20 mg 14C labelled oral dose of rabeprazole sodium, no unchanged medicinal</p><p>product was excreted in the urine. Approximately 90% of the dose was eliminated in urine mainly as</p><p>the two metabolites: a mercapturic acid conjugate (M5) and a carboxylic acid (M6), plus two</p><p>unknown metabolites. The remainder of the dose was recovered in faeces.</p><p><em>Gender</em></p><p>Adjusted for body mass and height, there are no significant gender differences in pharmacokinetic</p><p>parameters following a single 20 mg dose of rabeprazole.</p><p><em>Renal dysfunction</em></p><p>In patients with stable, end-stage, renal failure requiring maintenance haemodialysis (creatinine</p><p>clearance 5ml/min/1.73m2), the disposition of rabeprazole was very similar to that in healthy</p><p>volunteers. The AUC and the Cmax in these patients was about 35% lower than the corresponding</p><p>parameters in healthy volunteers. The mean half-life of rabeprazole was 0.82 hours in healthy</p><p>volunteers, 0.95 hours in patients during haemodialysis and 3.6 hours post dialysis. The clearance of</p><p>the medicinal product in patients with renal disease requiring maintenance haemodialysis was</p><p>approximately twice that in healthy volunteers.</p><p><em>Hepatic dysfunction</em></p><p>Following a single 20 mg dose of rabeprazole to patients with chronic mild to moderate hepatic</p><p>impairment the AUC doubled and there was a 2-3 fold increase in half-life of rabeprazole compared</p><p>to the healthy volunteers. However, following a 20 mg dose daily for 7 days the AUC had increased</p><p>to only 1.5-fold and the Cmax to only 1.2-fold. The half-life of rabeprazole in patients with hepatic</p><p>impairment was 12.3 hours compared to 2.1 hours in healthy volunteers. The pharmacodynamic</p><p>response (gastric pH control) in the two groups was clinically comparable.</p><p><em>Elderly</em></p><p>Elimination of rabeprazole was somewhat decreased in the elderly. Following 7 days of daily dosing</p><p>with 20 mg of rabeprazole sodium, the AUC approximately doubled, the Cmax increased by 60% and</p><p>t&frac12; increased by approximately 30% as compared to young healthy volunteers. However there was no</p><p>evidence of rabeprazole accumulation.</p><p><em>CYP2C19 Polymorphism</em></p><p>Following a 20 mg daily dose of rabeprazole for 7 days, CYP2C19 slow metabolisers, had AUC and</p><p>t&frac12; which were approximately 1.9 and 1.6 times the corresponding parameters in extensive</p><p>metabolisers whilst Cmax had increased by only 40%.</p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PreclinicalSafetyData">5.3 Preclinical Safety Data</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Non-clinical effects were observed only at exposures sufficiently in excess of the maximum human</p><p>exposure that make concerns for human safety negligible in respect of animal data.</p><p>Studies on mutagenicity gave equivocal results. Tests in mouse lymphoma cell line were positive, but</p><p><em>in vivo </em>micronucleus and <em>in vivo </em>and <em>in vitro </em>DNA repair tests were negative. Carcinogenicity studies</p><p>revealed no special hazard for humans.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. PHARMACEUTICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ExcipientsList">6.1 Excipients List</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><em>Tablet core:</em></p><p>Calcium hydoxide</p><p>Mannitol</p><p>Low-substituted hydroxypropyl cellulose</p><p>Sodium stearyl fumarate</p><p><em>Coating 1</em></p><p>Hypromellose</p><p>Talc</p><p><em>Gastro-resistant coating 2(10mg)</em></p><p>Hypromellose phthalate</p><p>Dibutyl sebacate</p><p>Yellow ferric oxide (E172)</p><p>Red ferric oxide (E172)</p><p>Titanium dioxide (E171)</p><p><em>Gastro-resistant coating 2(20mg)</em></p><p>Hypromellose phthalate</p><p>Dibutyl sebacate</p><p>Yellow ferric oxide (E172)</p><p>Titanium dioxide (E171)</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Incompatibilities">6.2. Incompatibilities</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Not applicable</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ShelfLife">6.3. Shelf Life</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                2 years.
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PrecautionsStorageConditions">6.4. Special precautions for storage</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Do not store above 30&deg;C. Store in the original package in order to protect from moisture.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ContainerContents">6.5. Nature and contents of container</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Al/Al blister with a desiccant:</p><p>AT/H/0260/01-02</p><p>5, 7, 10, 14, 15, 20, 25, 28, 30, 37, 50, 56, 60, 75, 90, 98, 100 and 120 gastro-resistant tablets</p><p>AT/H/0261/01-02</p><p>7, 10, 14, 20, 28, 30, 56, 60 and 98 gastro-resistant tablets</p><p>AT/H/0262/01-02</p><p>7, 10, 14, 15, 20, 28, 30, 37, 56, 60, 75, 98 and 120 gastro-resistant tablets</p><p>Not all pack sizes may be marketed.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialPrecautionsDisposal">6.6. Special precautions for disposal and other handling</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>No special precautions.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="AuthorizationMarketingHolder">7. MARKETING AUTHORISATION HOLDER</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Sandoz GmbH, Biochemiestraße 10
6250 - Kundl
Austria

            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="RevisionDateText">8. DATE OF REVISION OF THE TEXT</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                10/2017
            </div>
        </div>
    </div>
</div>

            }    </div>
    <div id="f-div" class="box-data">
        
<div class="row clearfix rtl">
    <div class="container-fluid">
        <!-- Basic Example -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>صورة المنتج على الرف</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic" data-slide-to="0" class="active"></li>
                        <li data-target="#carousel-example-generic" data-slide-to="1" class=""></li>
                        <li data-target="#carousel-example-generic" data-slide-to="2" class=""></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                            
                                <img src="/images/nodrugimags.png">
                        </div>

                    </div>

                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# Basic Example -->
        <!-- With Captions -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>الصورة الاساسية</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic_2" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic_2" data-slide-to="0" class=""></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="1" class="active"></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="2"></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                                <img src="/images/nodrugimags.png">
                        </div>
                    </div>
                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic_2" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic_2" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# With Captions -->
    </div>
</div>


    </div>

    <!-- #END# Tabs With Custom Animations -->
</div>
        <a style="background-image: url('../images/banner.png');"
           class="scroll-top">
            <img style="margin: 15px;" src="/images/icons/up-arrow2.png" width="35">
        </a>

        <div class="footer navbar-fixed-bottom">
            <small style="color: white; margin-left: 30px;">All Rights Reserved - SFDA &copy; 2020</small>
            <br class="visible-xs visible-sm"><br class="visible-xs visible-sm">

        </div>
    </section>


    <script src="/lib/json2/json2.js?v=w3DjWhUtDqy3bSJKv285C-2kagUtW9F64T9z3xRah8g"></script>
    <script src="/lib/jquery/dist/jquery.js?v=w4hyv6-vmv08RC2hK00wXgxDziKII9paMAbU_M-5dgY"></script>
    <script src="/lib/bootstrap/dist/js/bootstrap.js?v=T574NvJTWc-Pan8hAmnXXc0eZFiqKRp7xQ3sz5QiFOk"></script>
    <script src="/lib/moment/min/moment-with-locales.js?v=5f0RFtuChrGi6osDzegxXWf5yOkmx45i7J9fM1p6P5w"></script>
    <script src="/lib/jquery-validation/dist/jquery.validate.js?v=ZDzsHzuLAtqQVxXwbgRtfAPXQ7UAoJRXBAUDvc9G9CI"></script>
    <script src="/lib/blockUI/jquery.blockUI.js?v=KKcUNqwNyTLaXzvuMyFk6JisiQq6Hk7ZtrciXnEf3Z0"></script>
    <script src="/lib/toastr/toastr.js?v=s1ewxfN8Vn23TAVRLUk8XiQUAw6uWhhuPO9dmtYzUiA"></script>
    <script src="/lib/sweetalert/dist/sweetalert.min.js?v=aPktydUv1rN3mouQeXoKi3ioFTIQlULuqYeoTAA2ihY"></script>
    <script src="/lib/spin.js/spin.js?v=b1plKpQIB-XuGyjWec42MhmhpPzEPzFI3OC8Ia0XIoc"></script>
    <script src="/lib/spin.js/jquery.spin.js?v=i7H7HL08ldqUANgfQInE7LlU2uWUdQMCJ-Q7-_zLutY"></script>
    <script src="/lib/bootstrap-select/dist/js/bootstrap-select.js?v=tXulJKckrq2j2wo8a9hvmXLDEQwhGviPTIYmEzy1dNI"></script>
    <script src="/lib/jquery-slimscroll/jquery.slimscroll.js?v=ESVSX4dkOxamaRoYfcqPM2FfErhgfxS60fp1Fa8ou1w"></script>
    <script src="/lib/Waves/dist/waves.js?v=ZOMv1vwqpT_ezNZGhvr9jJTr_jqu3lYHB7vmpxD7HmA"></script>
    <script src="/lib/push.js/push.js?v=w347yqiscLjM_TxUKpqeUA1LDR3w5vshQpxpTsgkLhE"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/abp.js?v=EjNSmvtPSqCVK_xG_aTvOp8hmVM_7vwyd3hg45CAMGk"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.jquery.js?v=XEXcdRYb4eN3XoQCbnM-BSR6UifHRLsXYDIVFZ7Oc6Q"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.toastr.js?v=h3viOCmHM1K7HnYUuJPDvLchk2Ge8CoKvl6ZJfICgII"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.blockUI.js?v=vMuHbqHh635SKL2RG2qsGGCDyHg1yFeGqhPKpS34g4k"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.spin.js?v=djoKib6ssm5DDzbXLe5pD7ayfFg3siaoEk-BFYzQlvI"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.sweet-alert.js?v=fPp3O_ILaqD0UHiR721w1i4iBtxo3NH7yfldI5dg0_I"></script>
    <script src="/js/admin.js?v=nakObLuf3yPs2VlWrIris5w-48c36X3YIRrxIis7IKQ"></script>
    <script src="/js/main.js?v=x_HDlXByl0okIi4i04d4Q_fNr85GPQi1W8gjs82s-n8"></script>
    <script src="/view-resources/Views/Shared/_Layout.js?v=36YkLzPJaGejZMB10f2T6f1rMVIzDKq96kjfcnxcLVg"></script>


        <script src="/lib/jquery-validation/src/localization/messages_ar.js?v=6kzy-p-PtvkHPWdHWyjMOIfwhBFlUYYv9jnF7zJnpUI"></script>

    <!-- Dynamic scripts of ABP system (They are created on runtime and can not be bundled) -->
    <script src="/AbpServiceProxies/GetAll?v=638865394571695575" type="text/javascript"></script>
    <script src="/AbpScripts/GetScripts?v=638865394571695575" type="text/javascript"></script>
    <script src="/lib/signalr-client/signalr.min.js?v=1yGr-J4NjYMQVt6LP6vocjHIWhO-BFQLfdCs8x1Mv-U"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.signalr-client.js?v=jTdZBAadu6DXq0iDTFX6vsn4q6bFhKm3XfN8Jz6dSmg"></script>
    
    <!-- View specific scripts -->
    
    <script src="/view-resources/Views/Home/Index.js?v=mAIakROmG_IlahImCtfrMSdaLPTG5Uoh6Z0hM1g3cxw"></script>
    <script src="/view-resources/Views/Home/Result.js?v=0pEgOuTQc8ZyJaaOpJCG7ytkKSCkzEMYCHEJfKDWu4k"></script>
    <script src="/view-resources/Views/Home/DrugsSearch.js?v=04aRniTG_ClH5tABzf7EDwQgWVpkDNpjeJUDSGvOK_Y"></script>

</body>
</html>